---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-048043"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2026-07-13T20:38:21+00:00"
generated_at: "2026-07-13T20:39:07.275855+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Health reports preliminary Q2 revenue $9.6-$9.8M, above guidance but down 3-5% YoY

## Summary
- Preliminary Q2 2026 revenue of $9.6M-$9.8M, above revised guidance of $8.5M-$9.5M but down ~3-5% from $10.1M in Q2 2025.
- Consumable applicator sales set all-time records for both unit sales and revenue, indicating growing Ultramist adoption.
- Capital sales faced headwinds from customer stress and used Ultramist systems; trade-in program for certified pre-owned units showing success.
- Results are preliminary and subject to adjustment upon completion of quarter-end close and review procedures.

## SEC filing metadata
- accession: 0001628280-26-048043
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2026-07-13T20:38:21+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828026048043/0001628280-26-048043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828026048043/snwv-20260713.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-048043
- JSON: https://secwatch.observer/filing/0001628280-26-048043.json
- Plain text: https://secwatch.observer/filing/0001628280-26-048043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.